激光间质热疗治疗新诊断深部低级别胶质瘤的安全性与疗效:与手术队列比较的初步研究
本研究回顾性比较2013至2024年间接受激光间质热疗(LITT)或手术切除的深部新诊断低级别胶质瘤(nLGG)患者,LITT组15例,手术组51例。结果显示两组在围手术期并发症、新发神经功能缺损、辅助治疗率及生存结局上均无显著差异,按肿瘤体积1:1匹配后结论一致,提示LITT是深部nLGG的安全治疗选择。
要点
- LITT与手术切除在深部nLGG中围手术期并发症及新发神经功能缺损无显著差异。
- 两组辅助化疗、放疗比例及无进展生存、总生存均无统计学显著差异。
- 按肿瘤体积匹配后,LITT与开颅手术的结局仍无显著差异。
核心结论
- LITT是深部新诊断低级别胶质瘤的安全治疗选择,结局与手术切除相当。
研究设计与样本
- 回顾性队列研究,比较2013至2024年接受LITT(15例)或手术切除(51例)的单发深部nLGG患者。
- 采用贪婪最近邻算法按肿瘤体积生成1:1匹配队列进行亚组分析。
主要发现
- LITT组中位年龄46岁(IQR:34-53),男性占40.0%;手术组中位年龄38岁(IQR:29-54),男性占43.1%。
- 院内并发症(P=.999)、30天并发症(P=.999)、30天至3个月并发症(P=.713)及新发运动或言语缺损(P=.999)组间无显著差异。
- 术后辅助化疗(23.1% vs 46.9%,P=.217)与放疗(23.1% vs 44.7%,P=.210)比例无显著差异。
- 高危患者中LITT组辅助化疗(64.7 vs 77.7天)和放疗(36.0 vs 53.6天)时间更早,但无统计学显著性。
- Kaplan-Meier分析显示无进展生存与总生存组间无统计学显著差异,匹配分析后结论一致。
临床怎么用
- 对于因深部或功能区位置、年龄、衰弱或合并症而不适合开颅手术的新诊断低级别胶质瘤患者,LITT可作为安全替代方案。
局限性
- 本研究为初步研究,样本量小(LITT组15例),需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Laser interstitial thermal therapy (LITT) has emerged as a minimally invasive alternative to open craniotomy for patients deemed unsuitable for surgery due to deep-seated or eloquent lesion location, age, frailty, or comorbidities. However, its use in newly diagnosed deep-seated low-grade glioma (nLGG) has not been elucidated. We aimed to evaluate the safety and efficacy of LITT for deep-seated nLGG compared with a similar surgical cohort. METHODS: We retrospectively reviewed patients with unifocal, deep-seated nLGG treated with either LITT or surgical resection between 2013 and 2024. Demographic, perioperative, and follow-up data were compared between groups. Kaplan-Meier assessed progression-free and overall survival outcomes. To address baseline tumor volume differences, a subset analysis was performed using a greedy nearest-neighbor algorithm to generate a 1:1 matched cohort based on tumor volume. RESULTS: A total of 15 patients in the study group (median age 46 [IQR: 34-53] years, 40.0% men) were compared with 51 patients (median age 38 [IQR: 29-54] years, 43.1% men) in the control group. There were no significant differences in in-hospital complications ( P = .999), 30-day complications ( P = .999), or complications between 30 days and 3 months ( P = .713), new postoperative motor or speech deficits (0.999) between groups. Postoperative adjuvant chemotherapy (23.1% vs 46.9%, P = .217) and radiation (23.1% vs 44.7%, P = .210) rates did not differ significantly. Among high-risk patients, time to adjuvant chemotherapy (64.7 vs 77.7 days) and radiation (36.0 vs 53.6 days) was earlier in the LITT group, although not statistically significant. Kaplan-Meier analysis showed no statistically significant differences in progression-free survival or overall survival between groups. On matched pair analysis, there remained to be no statistically significant differences in outcomes observed between LITT and craniotomy groups. CONCLUSION: This pilot study is the first to suggest that LITT is a safe treatment option for patients with deep-seated nLGG, offering comparable outcomes with surgical resection.
引用
- Shah KH, Khalafallah AM, Knott MV, et al. The Safety and Efficacy of Laser Interstitial Thermal Therapy for Newly Diagnosed Deep-Seated Low-Grade Glioma: A Pilot Study Comparing Outcomes With a Surgical Cohort. Neurosurgery. 2026. PMID: 41642008. doi:10.1227/neu.0000000000003951
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。